Letters: Medicaid prior authorization policies for pediatric use of antipsychotic medications

JAMA - Journal of the American Medical Association

Volumn 313, Issue 9, 2015, Pages 966-968

  Schmid, Ian ^a   Burcu, Mehmet ^b   Zito, Julie M ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AGE; CHILD PSYCHIATRY; DRUG CONTROL; DRUG PROGRAM; DRUG USE; HEALTH CARE POLICY; HUMAN; LETTER; MEDICAID; MEDICAID PRIOR AUTHORIZATION POLICY; PEER REVIEW; PRESCRIPTION; PRIORITY JOURNAL; CHILD; GOVERNMENT REGULATION; INSURANCE; MENTAL DISORDERS; PATIENT REFERRAL; UNITED STATES;

ANTIPSYCHOTIC AGENTS; CHILD; GATEKEEPING; GOVERNMENT REGULATION; HEALTH POLICY; HUMANS; INSURANCE COVERAGE; MEDICAID; MENTAL DISORDERS; PEER REVIEW; UNITED STATES;

EID: 84924502655     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.0763     Document Type: Letter

References (6)

1. Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69(12): 1247-1256.
2. Crystal S, Olfson M, Huang C, Pincus H, Gerhard T. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood). 2009;28(5): w770-w781.
3. ABIM Foundation's Choosing Wisely. American Psychiatric Association: five things physicians and patients should question. http://www.choosingwisely.org/doctor-patient-lists/american-psychiatric-Association/. Accessed January 21, 2015.
4. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-Time use in children and adolescents. JAMA. 2009;302(16): 1765-1773.
5. Government Accountability Office. Children's mental health: concerns remain about appropriate services for children in Medicaid and foster care. http://www.gao.gov/assets/660/650716.pdf. Accessed January 21, 2015.
6. Stein BD, Leckman-Westin E, Okeke E, et al. The effects of prior authorization policies on Medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states. J Child Adolesc Psychopharmacol. 2014;24(7): 374-381.